No Slide Title
Download
Report
Transcript No Slide Title
Sheila Ryan Barnett, MD
Associate Professor of Anesthesiology
Harvard Medical School
Beth Israel Deaconess Medical Center
Boston, MA
> 65y
Population
USA
>85 y
year
surgeries per
60%
of patients of
general surgeons > 65y
Growth
in specialty
surgery expected: 3547%
Surgery per 100 00
procedures
16,000,000
Frequency of 12 common
procedures
800
700
600
500
400
300
200
100
0
<15 y
15-44 y 45-64 y >65 y
US 1999 – 2005
Li et al Anesthesiology 2009; 110: 698-9
Aging
& comorbidities
Medications – modifications
Medications – to avoid
Risk reduction
Inevitability
Aging involves physiological changes
AND
The pathophysiology of superimposed
disease
Steady Age-related Decline
in Organ Function
DISABILITIES COMMON
> 80y
What is your elderly patient’s
functional reserve?
Goal of the
preanesthetic
assessment
Minor complications poorly tolerated
Vascular stiffening, HTN, loss elasticity
Ventricular
• Increased impedance - wall hypertrophy
• decreased compliance, atrial dependence
Conduction issues:
• Decline in pacemaker cells, increase in atrial ectopy, &
conduction defects
Reduction in maximal HR –
• reduced response to catecholamines
Increased ischemic heart disease
Diastolic E/A : deceleration time / 250 pts /72 y
Diastolic
Function
Classification
%
Normal
Mild to
Moderate
37%
57.9%
Moderate
Severe
3.9%
1.7%
LVEF
54%
54.5%
61.5%
54%
43%
Philip Anesth Analg 2003 ; 97 1214-21
Thorax stiffens:
• reduced chest wall compliance & decreased thoracic
skeletal muscle mass = Increased work of maximal
breathing
Lung volumes change – reduced reserve volume
Decrease in elastic lung recoil – closing volume
increase
More V/Q mismatch & greater P(A-a) O2 gradient
Reduction in hypoxic and hypercarbic drive
Increased narcotic-induced apnea
Decreased pharyngeal reflexes - ? More aspiration
At age 80 paO2 is
about 58 mmHg !
Close to the edge at the start !
•
•
•
Case controlled study of Spinal surgery
patients
Compared patients with & without
Surgical Site Infection (SSI)
Independent risk factors:
– Long surgery OR 4.7 p<0.001
– ASA 3 + OR 9.7 p< 0.001
– Obesity 4.0 p<0.01
– Intraoperative oxygen <50% OR 12 p <0.001
•
Potential impact for elderly ?
Maragakis Anesth 2009; 110:556-62
Cortical
grey matter attrition –
• starts in middle age
Cerebral
atrophy – disease vs. aging
Increased
intracranial CSF
CBF
and auto regulation largely
maintained
Postoperative
cognitive dysfunction
1.
2.
3.
4.
Appreciate reduction in reserve
function
Understand age related organ changes
and the impact of common disease
Beware of ‘under-diagnosis’ e.g. DHF &
fluids
Provide supplemental extra oxygen,
(increased risk hypoxemia)
Dose
reduction
• Pharmacokinetic
• Pharmacodynamic
Interval
extension
Anesthesiology 2009; 110:1050-1060
What Dose?
Dose response
curve flattened in
the elderly patient
25 -50% reduction
JR Jacobs et al Anesth Analg 1995; 80:143
50%
reduction in initial doses for fentanyl
Significant decrease in
pharmacodynamic response
All
opioids increased risk apnea &
hypercapnia
Increased & delayed hemodynamic impact leading to
hypotension
Anesthesiology 2009; 110:1050-1060
“Start
low, go slow”
Benzodiazepines
• Low dosing with Midazolam to start
Opioids
• Beware respiratory depression
• Titrate to effect
Reduce
inhalation agent
Complete reversal of muscle relaxants
•
Anticholinergic side effects
– Central: Falls, delirium, cognitive dysfunction
– Peripheral : Dry mouth, constipation, confusion
• Anticholinergic Risk Scale
– List of drugs with varying anticholinergic properties
– Avoid or limit use if possible
•
Beers Criteria
– Long acting Benzodiazepines
– Multiple medications , many with anticholinergic
properties
•
High risk 3 points
– Atropine products
– Hydroxyzine (Atarax or Visteril)
– Diphenyhydramine (Benadryl)
– Promethazine (Phenergan)
•
Intermediate 2 points
– Prochlorperazine (Compazine)
•
Low 1 point
– Haloperidol
– Metoclopramide ( Reglan)
Rudolph Arch Int Med 2008; 168:508-13
Active metabolites normeperidine
• Renal excretion
• T ½ 14-21 hrs in elderly up to 30 hrs with CRI
Causes myoclonus, twitching and
seizures
Associated with delirium in elderly
Not recommended: use of meperidine in
patients 75 yrs or older for analgesia is
considered indicator of poor care by the
Assessing Care of vulnerable elderly.
•
Survey of 3000 community dwelling 57-85 y
– 81% minimum of 1 prescription drug (PD)
– 49% used dietary supplements
– 29% used at least 5 PDs
•
•
•
Among PD users 46% also used over the
counter drugs
4% at risk of major drug interaction, half
with non prescription drugs
Anti-coagulants most commonly involved
Unknown true impact on the
perianesthetic course
Qato JAMA 2008; 300 (24) 2876
1.
Avoid meperidine, long acting muscle
relaxants & benzo’s and anticholinergic
2.
Look for Polypharmacy
Timing
of surgery
Comprehensive preoperative
assessments
Beta Blockade … again
Meta-analysis
of >250,000 hip fx pts
Mortality at 30 days and 1 year
When
delayed over 48 hours
• 41% increase 30 d mortality
• 32% all cause mortality
How practical is this?
Shiga et al Can J Anesth 2008; 55:3; 146-154
120 patients
CGA
>60 y
• ADLs, IADLs (Barhtel Index) , comorbidity,
nutrition, MMSE
All
undergoing thoracic surgery
17%
post op complications
Predictors
–
• Low Barthel Index
• Surgery >300 mins
• Dementia – low MMSE
Fukuse Chest 2005; 127:886
400
patients > 70 y
Admitted to Intervention Ward
• Assessment, prevention treatment education
Assessment
day 1,3,7
Delirious patients in the Intervention ward
• Shorter duration: by day 7 30% vs 60% (p 0.001 )
• Shorter LOS: 9 vs 13 days (p 0.001)
• Reduced mortality: 2 vs. 9 patients died (p 0.03)
Lundstrom et al JAGS 2005:53:622
Mangano NEJM 1996;335:1713
•
•
100/200 patients received Atenolol
preop and for 7 days
Atenolol group improved survival 6
months & up to 2 y. Diabetes major
risk
But later data mixed results with
increased stroke and mortality
•
•
Observational study
5158 THR/THR patients
– 19% Beta blockers
• BB for 7 days (740)
• BB DOS & d/c’ed (252) 25%
– No BB (4166)
•
Total 1.5% (77) had POMI
• BB continued -22 POMI; 7 deaths
• BB discontinued -20 POMI; 19 deaths
• No BB – 35 POMI; 28 deaths
•
•
Event rate 3% BB vs. 7.9% for d/c’ed BB
In those discontinued beta blockers 2 fold increase in POMI
and death ( OR 2.0)
Van Klei et al Anesthesiology 2009; 111:117-24
60
50
45,370 patients
eligible for beta
blockade
40
30
20
10
0
65
75
80
85
90
>9
70
-6
5
-7
79
84
89
94
9
4
Vitagliano et al. JAGS 2004: 52:495
1.
2.
3.
4.
Careful preoperative assessment is a
priority
Get to the OR in a timely manner
Risk reduction medication – possible
beta blockers
Role of blood transfusions (not
discussed)
Unanticipated day of surgery deaths
– > 800 000 patients NSQIP - Death rate 0.08%
– Older age 60 vs. 67y and males P<0.0001
•
Complications increased death rate
•
PACU/ICU transfer most unstable
•
Opportunity to improve in 31% (chart
review )
Improvement: hypovolemia, MI and
transport period
•
Bishop Anesth Analg 2008 107: 1924-35
Veterans
Hospital Data
• 26 648 > 80 y
• 568 263 < 80 y
30
day mortality 8% vs. 3%, p<0.001
<2% if > 80y undergoing simple procedures
• TURP, IH, TKR, CEA
20%
had complications in > 80y
Once a complication – 26% vs 4% mortality
Hamel et al JAGS 2005; 53:424
Cardiac
events post non cardiac surgery
7700 patients, 83 (1%) Cardiac event
9 independent predictors
In patients experiencing a cardiac event,
intraoperative data more likely to show
episode of hypotension +/- tachycardia
Kheterpal et al Anesthesiology 2009; 110:58-66
Avoid
complications
Hemodynamics
Surgical mortality
Surgical morbidity
Turrentine et al J Am Coll Surg 2006; 203:865
300
unselected hip fractures
All received similar multimodal
anesthesia & defined rehabilitation
Outcomes:
• 30 d mortality 13%
• >30d 7 more died
Combined
mortality 16%
Foss & Kehlet Br J Anaesth 2005; 94: 24-29
47
deaths
• 28% (13) unavoidable, terminal cancer or
refused care
• 15% (7) probably unavoidable
• 34% (16) potentially avoidable ; active care
curtailed
• 23% (11) received maximal care ?
Potentially avoidable
Best outcomes if:
Avoid complications
Preoperative optimization
OR without delay (when feasible)
? Beta blockers / transfusions
Age appropriate drug dosing
Postoperative: pain meds, oxygen